MACITENTAN

Post-LOE

macitentan

ANDAORALTABLET
Approved
Dec 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT05167825Phase 3Completed

A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Started Nov 2022
7 enrolled
Pulmonary Arterial Hypertension
NCT04540744Phase 1Completed

A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil

Started Apr 2021
18 enrolled
Healthy
NCT04567602N/ACompleted

A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

Started Oct 2020
372 enrolled
Pulmonary Arterial Hypertension
NCT04500808Phase 1Completed

A Study of Macitentan, in Healthy Japanese Male Participants

Started Jul 2020
24 enrolled
Healthy
NCT04235270Phase 1Completed

A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants

Started Jan 2020
62 enrolled
Healthy